Vertex's Upgraded IgA Nephropathy Outlook Might Change The Case For Investing In Vertex (VRTX) [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
IgA nephropathy therapy and the planned use of a priority review voucher to accelerate regulatory timelines. This reassessment highlights how expectations around Vertex's kidney pipeline and broader gene-editing portfolio are becoming increasingly central to how the business is being evaluated. We'll now examine how this analyst upgrade, driven by optimism about Vertex's IgA nephropathy candidate and regulatory acceleration, shapes its investment narrative. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit To own Vertex, you need to believe it can use its cystic fibrosis cash flows to build a broader portfolio in kidney disease, gene editing, and other serious conditions, while managing pricing and regulatory pressures. Wolfe Research's upgrade tied to the IgA nephropathy program reinforces that kidney and gene editing assets are now seen as key near term catalysts, but it does not materially change the bigg
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance]Yahoo! Finance
- Here's What to Expect From Vertex Pharmaceuticals' Next Earnings Report [Yahoo! Finance]Yahoo! Finance
- Here's What Lifted Vertex Pharmaceuticals (VRTX) in Q4 [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Sanford C. Bernstein to an "outperform" rating.MarketBeat
- Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 11/3/25 - Beat
VRTX
Sec Filings
- 1/9/26 - Form 4
- 1/8/26 - Form 4
- 1/7/26 - Form 144
- VRTX's page on the SEC website